Gujarat Themis Biosyn, 506879, GUJTHEM Share Price, Rating, Research, Analysis, Fundamental & Historical Data

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

5,565.94
114.32
1

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

5,719.72
0.16%
5.31

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

16.60
7.62
-0.79

EBITDA CAGR (%)

10 Years
5 Years
3 Years

28.87
5.65
-0.60

PAT CAGR (%)

10 Years
5 Years
3 Years

26.70
1.37
-7.59

P:E (Median)

8 Years
5 Years
3 Years

19.05
48.30
67.43

P:BV (Average)

8 Years
5 Years
3 Years

10.21
11.41
14.15

EV:EBITDA (Average)

8 Years
5 Years
3 Years

23.32
32.50
45.76

Earnings Forecasts:

(Updated: 19-09-2026)

Description 2026 2027 2028 2029
Adj EPS 37 10 - -
P/E Ratio 11.55 42.74 - -
Revenue - - - -
EBITDA - - - -
Net Income - - - -
ROA - - - -
P/B Ratio - - - -
ROE - - - -
FCFF - - - -
FCFF Yield - - - -
Net Debt - - - -
BVPS - - - -

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Jun 26 Jun 25 Var% Mar 26 Mar 25 Var% Dec 25 Dec 24 Var% Sep 25 Sep 24 Var%
Net Sales 43.79 35.87 22.08% 44.23 37.74 17.20% 43.37 39.52 9.74% 42.35 34.72 21.98%
Expenses 23.00 21.95 4.78% 24.87 21.70 14.61% 22.06 20.65 6.83% 21.41 19.32 10.82%
EBITDA 20.79 13.92 49.35% 19.36 16.04 20.70% 21.31 18.87 12.93% 20.94 15.39 36.06%
EBIDTM 47.49% 38.81% 43.77% 42.50% 49.13% 47.74% 49.46% 44.33%
Other Income 0.13 0.27 -51.85% 0.92 1.35 -31.85% 0.42 0.24 75.00% 0.82 0.32 156.25%
Interest 1.79 0.04 4,375.00% 1.91 0.07 2,628.57% 0.96 0.14 585.71% 0.04 0.08 -50.00%
Depreciation 3.97 2.03 95.57% 4.04 1.23 228.46% 3.89 1.56 149.36% 2.96 1.44 105.56%
PBT 15.17 12.12 25.17% 14.34 16.09 -10.88% 16.87 17.40 -3.05% 18.76 14.19 32.21%
Tax 4.10 3.06 33.99% 3.45 4.09 -15.65% 4.41 4.43 -0.45% 4.50 3.63 23.97%
PAT 11.07 9.06 22.19% 10.89 12.00 -9.25% 12.46 12.97 -3.93% 14.27 10.57 35.00%
PATM 25.27% 25.26% 24.62% 31.79% 28.74% 32.83% 33.68% 30.44%
EPS 1.02 0.83 22.89% 1.00 1.10 -9.09% 1.14 1.19 -4.20% 1.31 0.97 35.05%

Description Jun 26 Jun 25 Var% Mar 26 Mar 25 Var% Dec 25 Dec 24 Var% Sep 25 Sep 24 Var%
Net Sales 43.79 35.87 22.08% 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Expenses 23.00 21.95 4.78% 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBITDA 20.79 13.92 49.35% 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBIDTM 47.49% 38.81% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.13 0.27 -51.85% 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Interest 1.79 0.04 4,375.00% 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Depreciation 3.97 2.03 95.57% 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PBT 15.17 12.12 25.17% 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Tax 4.10 3.06 33.99% 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT 11.07 9.06 22.19% 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PATM 25.27% 25.26% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 1.02 0.83 22.89% 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0

Annual Results

Standalone Figures in Rs. Crores

Description TTM Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Net Sales 173.74 165.82 150.80 169.82 148.39 114.85 90.56 85.12 41.05 38.80 35.69 Net Sales Growth 17.51% 9.96% -11.20% 14.44% 29.20% 26.82% 6.39% 107.36% 5.80% 8.71% Cost Of Goods Sold 18.59 19.94 23.22 35.72 25.77 16.10 15.13 11.05 1.04 2.15 1.48 Gross Profit 155.15 145.88 127.58 134.10 122.61 98.75 75.43 74.07 40.01 36.65 34.21 GP Margin 89.30% 87.97% 84.60% 78.97% 82.63% 85.98% 83.29% 87.02% 97.47% 94.46% 95.85% Total Expenditure 91.34 89.41 81.96 91.09 74.76 56.81 50.23 53.29 33.69 32.56 29.64 Power & Fuel Cost - 31.89 26.63 26.53 26.41 21.73 16.57 22.86 20.20 19.33 17.99 % Of Sales - 19.23% 17.66% 15.62% 17.80% 18.92% 18.30% 26.86% 49.21% 49.82% 50.41% Employee Cost - 14.99 11.44 10.21 7.75 7.08 7.11 6.43 5.17 4.46 4.42 % Of Sales - 9.04% 7.59% 6.01% 5.22% 6.16% 7.85% 7.55% 12.59% 11.49% 12.38% Manufacturing Exp. - 12.62 12.95 13.64 10.62 9.00 9.35 10.97 5.67 5.01 4.43 % Of Sales - 7.61% 8.59% 8.03% 7.16% 7.84% 10.32% 12.89% 13.81% 12.91% 12.41% General & Admin Exp. - 7.40 4.98 4.02 2.53 1.43 1.16 0.93 0.95 0.95 0.76 % Of Sales - 4.46% 3.30% 2.37% 1.70% 1.25% 1.28% 1.09% 2.31% 2.45% 2.13% Selling & Distn. Exp. - 0.39 0.27 0.42 1.04 0.31 0.38 0.54 0.32 0.03 0.03 % Of Sales - 0.24% 0.18% 0.25% 0.70% 0.27% 0.42% 0.63% 0.78% 0.08% 0.08% Miscellaneous Exp. - 2.17 2.46 0.53 0.64 1.15 0.53 0.49 0.35 0.64 0.03 % Of Sales - 1.31% 1.63% 0.31% 0.43% 1.00% 0.59% 0.58% 0.85% 1.65% 1.49% EBITDA 82.40 76.41 68.84 78.73 73.63 58.04 40.33 31.83 7.36 6.24 6.05 EBITDA Margin 47.43% 46.08% 45.65% 46.36% 49.62% 50.54% 44.53% 37.39% 17.93% 16.08% 16.95% Other Income 2.29 2.43 2.43 4.37 6.59 4.05 3.27 1.70 2.21 0.17 0.36 Interest 4.70 3.84 0.36 0.23 0.18 0.83 0.98 0.92 0.16 0.42 0.41 Depreciation 14.86 12.92 5.37 3.54 2.58 2.23 1.73 1.36 1.22 1.15 1.12 PBT 65.14 62.09 65.54 79.33 77.46 59.03 40.88 31.26 8.20 4.84 4.88 Tax 16.46 15.41 16.77 20.17 19.50 15.41 10.70 7.58 1.79 0.97 0.51 Tax Rate 25.27% 24.82% 25.59% 25.43% 25.17% 26.11% 26.17% 24.25% 21.83% 20.04% 10.45% PAT 48.69 46.68 48.77 59.16 57.97 43.62 30.18 23.67 6.41 3.87 4.38 PAT before Minority Interest 48.69 46.68 48.77 59.16 57.97 43.62 30.18 23.67 6.41 3.87 4.38 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 28.02% 28.15% 32.34% 34.84% 39.07% 37.98% 33.33% 27.81% 15.62% 9.97% 12.27% PAT Growth 9.17% -4.29% -17.56% 2.05% 32.90% 44.53% 27.50% 269.27% 65.63% -11.64% EPS 4.47 4.28 4.47 5.43 5.32 4.00 2.77 2.17 0.59 0.36 0.40

Results Balance Sheet

Standalone Figures in Rs. Crores

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Shareholder's Funds 287.77 248.38 201.38 149.15 103.32 69.95 42.20 18.52 12.11 8.21 Share Capital 10.90 10.90 7.26 7.26 7.26 7.26 7.26 7.26 7.26 7.26 Total Reserves 276.87 237.49 194.11 141.88 96.06 62.68 34.93 11.26 4.85 0.95 Non-Current Liabilities 136.51 32.37 3.58 1.90 2.02 2.49 4.54 1.43 0.46 1.32 Secured Loans 128.06 29.64 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.32 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 3.18 0.00 0.00 0.40 Long Term Provisions 1.21 0.77 0.69 0.60 0.58 0.51 0.49 0.51 0.46 0.55 Current Liabilities 89.80 37.26 36.20 35.70 31.67 25.87 24.29 12.81 7.92 11.90 Trade Payables 36.65 14.65 9.91 9.54 6.62 3.54 7.45 5.60 5.58 7.14 Other Current Liabilities 27.10 5.63 5.94 4.94 8.60 10.87 9.16 7.13 2.28 3.56 Short Term Borrowings 14.94 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.00 1.14 Short Term Provisions 11.10 16.98 20.35 21.22 16.45 11.46 7.69 0.08 0.06 0.06 Total Liabilities 514.08 318.01 241.16 186.75 137.01 98.31 71.03 32.76 20.49 21.43 Net Block 288.98 41.29 38.02 32.66 19.43 18.95 17.08 14.61 10.59 10.63 Gross Block 317.44 59.33 51.21 44.04 28.24 25.52 21.93 18.10 12.86 11.75 Accumulated Depreciation 28.46 18.04 13.19 11.38 8.81 6.57 4.85 3.49 2.27 1.12 Non Current Assets 414.64 249.34 173.55 104.60 44.11 24.94 34.94 24.72 12.65 13.18 Capital Work in Progress 121.13 184.41 91.22 20.59 12.70 2.07 0.36 0.95 0.17 0.20 Non Current Investment 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 Long Term Loans & Adv. 4.49 22.26 9.92 9.81 2.77 2.61 2.38 2.45 1.62 2.08 Other Non Current Assets 0.04 1.39 34.39 41.53 9.21 1.31 15.12 6.71 0.27 0.27 Current Assets 99.43 68.67 67.60 82.15 92.90 73.37 36.08 8.04 7.84 8.25 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.01 0.01 0.00 Inventories 15.42 5.05 3.33 14.62 11.61 6.05 6.03 0.34 0.46 0.51 Sundry Debtors 60.92 31.24 27.03 17.91 25.12 14.71 20.23 5.80 2.72 6.99 Cash & Bank 6.09 12.55 8.16 9.33 12.35 27.64 2.08 1.70 4.46 0.41 Other Current Assets 17.01 0.37 0.93 1.37 43.82 24.96 7.74 0.20 0.20 0.35 Short Term Loans & Adv. 16.52 19.47 28.16 38.93 42.06 22.98 7.44 0.05 0.06 0.21 Net Current Assets 9.64 31.41 31.40 46.45 61.23 47.50 11.80 -4.77 -0.08 -3.65 Total Assets 514.07 318.01 241.15 186.75 137.01 98.31 71.02 32.76 20.49 21.43

Cash Flow

Standalone Figures in Rs. Crores

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Cash From Operating Activity 48.78 91.03 64.21 39.48 40.31 10.53 0.63 0.69 5.59 2.80 PBT 62.09 65.54 79.33 77.46 59.03 40.88 31.26 8.20 4.84 4.88 Adjustment 15.22 5.09 0.46 -2.45 0.15 -0.24 0.65 -3.92 1.44 1.48 Changes in Working Capital -17.88 36.88 4.19 -15.11 -4.36 -19.98 -24.30 -2.45 -0.11 -2.94 Cash after chg. in Working capital 59.43 107.51 83.99 59.90 54.83 20.66 7.60 1.83 6.17 3.43 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -10.65 -16.49 -19.78 -20.42 -14.52 -10.13 -6.97 -1.14 -0.59 -0.63 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -172.28 -111.82 -55.21 -20.41 -29.83 -2.25 -2.98 -5.75 -1.03 -2.51 Net Fixed Assets -194.83 -101.31 -77.80 -23.69 -13.35 -5.30 -3.24 -6.02 -1.08 29.70 Net Investments 0.00 0.00 0.00 0.00 0.00 0.01 0.00 0.00 0.00 0.00 Others 22.55 -10.51 22.59 3.28 -16.48 3.04 0.26 0.27 0.05 -32.21 Cash from Financing Activity 114.93 26.01 -8.59 -13.27 -14.00 -5.16 2.10 5.29 -3.80 -0.19 Net Cash Inflow / Outflow -8.57 5.22 0.41 5.79 -3.51 3.12 -0.26 0.23 0.76 0.10 Opening Cash & Equivalents 11.69 6.47 6.05 0.26 3.97 0.86 1.12 0.89 0.13 0.03 Closing Cash & Equivalent 3.12 11.69 6.47 6.05 0.46 3.97 0.86 1.12 0.89 0.13

Financial Ratios

Standalone

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Book Value (Rs.) 26.41 22.79 18.48 13.69 14.22 48.14 29.04 12.75 8.34 5.65 ROA 11.22% 17.44% 27.65% 35.81% 37.08% 35.65% 45.62% 24.07% 18.45% 24.25% ROE 17.41% 21.69% 33.76% 45.92% 50.35% 53.82% 77.99% 41.85% 38.06% 72.63% ROCE 18.16% 27.48% 45.40% 61.51% 67.91% 67.89% 85.96% 44.88% 42.22% 54.67% Fixed Asset Turnover 0.88 2.73 3.57 4.11 4.27 3.82 4.25 2.65 3.15 1.34 Receivable days 101.42 70.51 48.29 52.91 63.29 70.42 55.80 37.88 45.67 46.80 Inventory Days 22.53 10.13 19.29 32.26 28.06 24.34 13.65 3.55 4.57 4.73 Payable days 469.41 193.03 99.37 114.42 115.10 132.50 42.12 60.55 72.03 77.99 Cash Conversion Cycle -345.46 -112.39 -31.80 -29.25 -23.75 -37.74 27.33 -19.12 -21.79 -26.47 Total Debt/Equity 0.56 0.12 0.00 0.00 0.00 0.04 0.19 0.32 0.05 0.49 Interest Cover 17.18 181.05 347.14 440.64 72.31 42.66 34.85 52.71 12.59 12.96

Top Investors:

quant mutual fund - quant manufacturing fund

ayushmat ltd

llp

Annual Reports:

News Update:

Gujarat Themis Biosyn raises Rs 585 crore through NCDs
17th Sep 2026, 11:42 AM

The Committee of the Board of Directors of the Company at its meeting held on September 16, 2026, has allotted the same
Read More
Gujarat Themis Biosyn gets nod to raise Rs 585 crore via NCDs
11th Sep 2026, 12:59 PM

The Board of Directors of the Company at its meeting held on September 10, 2026, has inter-alia considered and approved the same
Read More
Guj. Themis Biosyn - Quarterly Results
8th Aug 2026, 00:00 AM

Read More

Gujarat Themis Biosyn Ltd.

Pharmaceuticals & Drugs

BSE: 506879 | NSE: GUJTHEM

Stock Summary

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Earnings Forecasts:

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Standalone Figures in Rs. Crores

Results Balance Sheet

Standalone Figures in Rs. Crores

Cash Flow

Standalone Figures in Rs. Crores

Financial Ratios

Standalone

Top Investors:

Annual Reports:

News Update:

Gujarat Themis Biosyn Ltd.

Pharmaceuticals & Drugs

BSE: 506879 | NSE: GUJTHEM

Stock Summary

Shareholding Pattern

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Earnings Forecasts:

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Standalone Figures in Rs. Crores

Results Balance Sheet

Standalone Figures in Rs. Crores

Cash Flow

Standalone Figures in Rs. Crores

Financial Ratios

Standalone

Top Investors:

Annual Reports:

News Update: